BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 22071579)

  • 1. TLE1 is expressed in the majority of primary pleuropulmonary synovial sarcomas.
    Lino-Silva LS; Flores-Gutiérrez JP; Vilches-Cisneros N; Domínguez-Malagón HR
    Virchows Arch; 2011 Dec; 459(6):615-21. PubMed ID: 22071579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of TLE1, INI1, β-catenin, Claudin1, CK7, CK19, SS18 and calponin in synovial sarcoma.
    Madakshira MG; Radotra BD; Kaman L; Saikia UN
    Indian J Pathol Microbiol; 2021; 64(4):707-716. PubMed ID: 34673590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary pleuropulmonary and mediastinal synovial sarcoma: a clinicopathologic and molecular study of 26 genetically confirmed cases in the largest institution of southwest China.
    Lan T; Chen H; Xiong B; Zhou T; Peng R; Chen M; Ye F; Yao J; He X; Wang Y; Zhang H
    Diagn Pathol; 2016 Jul; 11(1):62. PubMed ID: 27401493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TLE1 expression is not specific for synovial sarcoma: a whole section study of 163 soft tissue and bone neoplasms.
    Kosemehmetoglu K; Vrana JA; Folpe AL
    Mod Pathol; 2009 Jul; 22(7):872-8. PubMed ID: 19363472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical validation of TLE1, a novel marker, for synovial sarcomas.
    Rekhi B; Basak R; Desai SB; Jambhekar NA
    Indian J Med Res; 2012 Nov; 136(5):766-75. PubMed ID: 23287123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity of TLE1 expression in unclassified high-grade sarcomas for the diagnosis of synovial sarcoma.
    Valente AL; Tull J; Zhang S
    Appl Immunohistochem Mol Morphol; 2013 Oct; 21(5):408-13. PubMed ID: 23197007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TLE1 is a robust diagnostic biomarker for synovial sarcomas and correlates with t(X;18): analysis of 319 cases.
    Knösel T; Heretsch S; Altendorf-Hofmann A; Richter P; Katenkamp K; Katenkamp D; Berndt A; Petersen I
    Eur J Cancer; 2010 Apr; 46(6):1170-6. PubMed ID: 20189377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective evaluation of TLE1 as a diagnostic immunohistochemical marker in synovial sarcoma.
    Jagdis A; Rubin BP; Tubbs RR; Pacheco M; Nielsen TO
    Am J Surg Pathol; 2009 Dec; 33(12):1743-51. PubMed ID: 19809272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue microarray based immunohistochemical study of TLE1 in synovial sarcoma and its histologic mimics.
    Sivakoti S; Uppin SG; Uppin MS; Tara RP; Prayaga AK; Challa S
    Indian J Pathol Microbiol; 2021; 64(2):310-315. PubMed ID: 33851625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Application of TLE1 expression and fluorescence in-situ hybridization in diagnosing poorly differentiated synovial sarcoma].
    Mao RJ; Li QM; Fang HQ; Han FL; Huang XF; Wu YX; Zeng M
    Zhonghua Bing Li Xue Za Zhi; 2011 Jun; 40(6):403-5. PubMed ID: 21914350
    [No Abstract]   [Full Text] [Related]  

  • 11. [Roles of immunohistochemistry and detection of SYT-SSX fusion gene in diagnosis of synovial sarcoma].
    Sun Y; Sun BC; Zhao XL; Wang J; Chen J; Li XQ; Feng YM; Fang ZW; Hao XS
    Zhonghua Bing Li Xue Za Zhi; 2007 Jul; 36(7):480-4. PubMed ID: 17845763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical staining for TLE1 distinguishes synovial sarcoma from histologic mimics.
    Foo WC; Cruise MW; Wick MR; Hornick JL
    Am J Clin Pathol; 2011 Jun; 135(6):839-44. PubMed ID: 21571956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transducer-like enhancer of split 1 (TLE1) expression as a diagnostic immunohistochemical marker for synovial sarcoma and its association with morphological features.
    Bakrin IH; Hussain FA; Tuan Sharif SE
    Malays J Pathol; 2016 Aug; 38(2):117-22. PubMed ID: 27568668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transducer-like enhancer of split 1 (TLE1) as a novel biomarker for diagnosis of synovial sarcoma correlates with translocation t(X;18): a study of 155 cases in China.
    Li Y; Zhang X; Wang A; Ding S; Li Y; Wang H; Lv Y; Shi H
    Int J Clin Exp Pathol; 2019; 12(1):251-258. PubMed ID: 31933740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TLE1 expression in malignant mesothelioma.
    Matsuyama A; Hisaoka M; Iwasaki M; Iwashita M; Hisanaga S; Hashimoto H
    Virchows Arch; 2010 Nov; 457(5):577-83. PubMed ID: 20857142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of TLE1 in Malignant Melanoma With Spindle Cell Morphology: A Potential Diagnostic Pitfall.
    Morrell TJ; Xiong Y; Deng A; Dresser K; O'Donnell P; Cornejo KM
    Int J Surg Pathol; 2019 May; 27(3):259-262. PubMed ID: 30301396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Utility of NKX2.2 and TLE1 Immunohistochemistry in the Differentiation of Ewing Sarcoma and Synovial Sarcoma.
    Rooper LM; Sharma R; Gocke CD; Belchis DA
    Appl Immunohistochem Mol Morphol; 2019 Mar; 27(3):174-179. PubMed ID: 28800015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pleural malignant mesothelioma versus pleuropulmonary synovial sarcoma: a clinicopathological study of 22 cases with molecular analysis and survival data.
    Klebe S; Prabhakaran S; Hocking A; Pulford E; Moore S; Nicola M; Allen PW; Henderson DW
    Pathology; 2018 Oct; 50(6):629-634. PubMed ID: 30170702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TLE1 as a diagnostic immunohistochemical marker for synovial sarcoma emerging from gene expression profiling studies.
    Terry J; Saito T; Subramanian S; Ruttan C; Antonescu CR; Goldblum JR; Downs-Kelly E; Corless CL; Rubin BP; van de Rijn M; Ladanyi M; Nielsen TO
    Am J Surg Pathol; 2007 Feb; 31(2):240-6. PubMed ID: 17255769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of characteristic 'Weak to Absent' INI1/SMARCB1/BAF47 expression in diagnosis of synovial sarcomas.
    Rekhi B; Vogel U
    APMIS; 2015 Jul; 123(7):618-28. PubMed ID: 25912315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.